DCPH - Deciphera Pharmaceuticals GAAP EPS of -$0.60 beats by $0.06 revenue of $32.5M beats by $2.39M August, 04 2022 07:22 AM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals press release ( NASDAQ: DCPH ): Q2 GAAP EPS of -$0.60 beats by $0.06 . Revenue of $32.5M (+37.9% Y/Y) beats by $2.39M . For further details see: Deciphera Pharmaceuticals GAAP EPS of -$0.60 beats by $0.06, revenue of $32.5M beats by $2.39M